Optimization of DNA vaccination against cutaneous leishmaniasis

Author： Mendez S.   Belkaid Y.   Seder R.A.   Sacks D.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.31, 2002-11, pp. : 3702-3708

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapy of murine cutaneous leishmaniasis by DNA vaccination

By Handman E.   Noormohammadi A.H.   Curtis J.M.   Baldwin T.   Sjolander A.  

Vaccine, Vol. 18, Iss. 26, 2000-07 ,pp. : 3011-3017

Elsevier

Access to resources Recommend Favorite

A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major

By Rafati S.   Salmanian A.-H.   Taheri T.   Vafa M.   Fasel N.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3369-3375

Elsevier

Access to resources Recommend Favorite

Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB/c and C57BL/6 mice against cutaneous leishmaniasis

By Pinto E.F.   de Mello Cortezia M.   Rossi-Bergmann B.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3534-3541

Elsevier

Access to resources Recommend Favorite

The protective capacities of histone H1 against experimental murine cutaneous leishmaniasis

By Solioz N.   Blum-Tirouvanziam U.   Jacquet R.   Rafati S.   Corradin G.   Mauel J.   Fasel N.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 850-859

Elsevier

Access to resources Recommend Favorite

Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani

By Paraguai de Souza E.   Bernardo R.R.   Palatnik M.   Palatnik de Sousa C.B.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3104-3115

Elsevier

Access to resources Recommend Favorite